Richard M. Blau Attorney At Law


Richard M. Blau - Attorney at Law

Shareholder

T 813-273-5000
F 813-273-5145
D 813-273-5128
Tampa 401 East Jackson Street Suite 2700 Tampa, Florida 33602

Richard M. Blau is a shareholder with the law firm of GrayRobinson, P.A. He is chair of the law firm's regulated products law department and heads up the firm’s cannabis industry focusing on the rules and regulations that govern the production, processing, distribution, sale and dispensing of medical marijuana and related cannabis products.

Mr. Blau has been rated “Band 1” by Chambers USA since 2007. He also is listed in Best Lawyers in America, and is “AV” rated by Martindale-Hubbell. A substantial portion of Mr. Blau’s professional efforts are focused on trade regulations, litigation and dispute resolution involving regulated products such as alcohol beverages, tobacco, firearms and explosives, and most recently medical marijuana and cannabis. He has been involved extensively with the legalization of cannabis in Florida since its outset with passage of the Compassionate Medical Cannabis Act of 2014 (SB 1030) into law on June 6, 2014.

An elected member of The American Law Institute, Richard also is a member of The Florida Bar, The New York Bar, The Bar Association of the District of Columbia, the American Bar Association and the Federal Bar Association. Additionally, Mr. Blau served for over eight years as the Chair of the American Bar Association’s Committee on Beverage Alcohol Practice. He currently serves as a board member of the Academy of Hospitality Industry Attorneys (AHIA).

Mr. Blau has written and lectured extensively on issues related to the legalization of the medical marijuana and broader cannabis industries, as well as the interaction between federal and state laws regulating cannabis.  Most recently, he was the keynote speaker in the National Business Institute’s 2017 seminar Medical Marijuana in Florida, as well as a lecturer on Mastering Cannabis & Marijuana Regulation for The Rossdale Group.  Mr. Blau has been interviewed regarding medical marijuana issues by newspaper, radio and television journalists from numerous media outlets.